Preclinical Evaluation of TSPO and MAO-B PET Radiotracers in an LPS Model of Neuroinflammation

PET Clin. 2021 Apr;16(2):233-247. doi: 10.1016/j.cpet.2020.12.003.

Abstract

Discovery of novel PET radiotracers targeting neuroinflammation (microglia and astrocytes) is actively pursued. Employing a lipopolysaccharide (LPS) rat model, this longitudinal study evaluated the translocator protein 18-kDa radiotracer [18F]FEPPA (primarily microglia) and monoamine oxidase B radiotracers [11C]L-deprenyl and [11C]SL25.1188 (astrocytes preferred). Increased [18F]FEPPA binding peaked at 1 week in LPS-injected striatum whereas increased lazabemide-sensitive [11C]L-deprenyl binding developed later. No increase in radiotracer uptake was observed for [11C]SL25.1188. The unilateral intrastriatal LPS rat model may serve as a useful tool for benchmarking PET tracers targeted toward distinct phases of neuroinflammatory reactions involving both microglia and astrocytes.

Keywords: LPS rat model; MAO-B; Neuroinflammation; PET biomarkers; TSPO.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / diagnostic imaging
  • Carrier Proteins
  • Humans
  • Lipopolysaccharides*
  • Longitudinal Studies
  • Microglia / metabolism
  • Monoamine Oxidase*
  • Positron-Emission Tomography
  • Rats
  • Receptors, GABA / metabolism
  • Receptors, GABA-A

Substances

  • Carrier Proteins
  • Lipopolysaccharides
  • Receptors, GABA
  • Receptors, GABA-A
  • TSPO protein, human
  • Tspo protein, rat
  • Monoamine Oxidase